Jean-Philippe Langevin, M.D.


Dr. Langevin’s laboratory focuses on the application of neuromodulation technology, invasive and non-invasive, to the treatment of neurological and psychiatric disorders. Potential targets are initially studied in animal models of the disorder and promising results are translated into clinical trials. He is currently conducting a clinical trial using deep brain stimulation of the amygdala to treat severe treatment-resistant post-traumatic stress disorder. In addition, he is studying the effect of non-invasive external trigeminal nerve stimulation in the treatment of chronic mild traumatic brain injury.